AI assistant
Riot Platforms, Inc. — Director's Dealing 2017
Apr 10, 2017
30793_dirs_2017-04-10_cd2f4f14-485e-437b-9a6c-e1cf8c0beb8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bioptix, Inc. (BIOP)
CIK: 0001167419
Period of Report: 2017-04-07
Reporting Person: Beeghley Michael Martin (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-07 | Stock Option (Right to Buy) | $4.02 | A | 20000 | Acquired | 2027-04-07 | Common Stock (20000) | Direct |
Footnotes
F1: (1) Represents a grant of an option to purchase the Company's common stock (the "Options Award") at an exercise price equal to the fair market value on the date of issuance, as determined in accordance with NASDAQ rules, pursuant to the Company's 2016 Equity Incentive Plan (the "2016 Plan"). The Options Award shall vest in 24 equal monthly installments over a two year period, beginning on the one month anniversary of the date of issuance. The vesting of the Options Award is subject to acceleration upon the occurrence of a "Qualifying Transaction", as such term is defined in the 2016 Plan.
F2: The Options Award was granted in connection with the Reporting Person's appointment as Chief Executive Officer of the Company.